Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Prime Medicine Inc.

    NASDAQ: PRME · Real-Time Price · USD
    2.26
    -0.20 (-8.13%)
    At close: Jun 25, 2025, 10:15 AM

    Prime Medicine Statistics

    Share Statistics

    Prime Medicine has 131.29M shares outstanding. The number of shares has increased by 9.27% in one year.

    Shares Outstanding

    n/a
    		 131.29M

    Shares Change (YoY)

    n/a
    		 9.27%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 52.96%

    Shares Floating

    n/a
    		 51.69M

    Failed to Deliver (FTD) Shares

    n/a
    		 2,778

    FTD / Avg. Volume

    n/a
    		 0.13%

    Short Selling Information

    The latest short interest is 17.97M, so 13.68% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 17.97M

    Short % of Shares Out

    n/a
    		 13.68%

    Short % of Float

    n/a
    		 26.5%

    Short Ratio (days to cover)

    n/a
    		 5.17

    Valuation Ratios

    The PE ratio is -1.77 and the forward PE ratio is -2.15. Prime Medicine's PEG ratio is 0.07.

    PE Ratio

    n/a
    		 -1.77

    Forward PE

    n/a
    		 -2.15

    PS Ratio

    n/a
    		 116.1

    Forward PS

    n/a
    		 10

    PB Ratio

    n/a
    		 2.26

    P/FCF Ratio

    n/a
    		 -2.66

    PEG Ratio

    n/a
    		 0.07
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Prime Medicine.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 5.58, with a Debt / Equity ratio of 0.27.

    Current Ratio

    n/a
    		 5.58

    Quick Ratio

    n/a
    		 5.58

    Debt / Equity

    n/a
    		 0.27

    Debt / EBITDA

    n/a
    		 -0.21

    Debt / FCF

    n/a
    		 -0.31

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $13,939.25

    Profits Per Employee

    n/a
    		 $-915,336.45

    Employee Count

    n/a
    		 214

    Asset Turnover

    n/a
    		 0.01

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -57.56% in the last 52 weeks. The beta is 1.55, so Prime Medicine's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.55

    52-Week Price Change

    n/a
    		 -57.56%

    50-Day Moving Average

    n/a
    		 1.48

    200-Day Moving Average

    n/a
    		 2.66

    Relative Strength Index (RSI)

    n/a
    		 78.66

    Average Volume (20 Days)

    n/a
    		 2,165,437

    Income Statement

    In the last 12 months, Prime Medicine had revenue of 2.98M and earned -195.88M in profits. Earnings per share was -1.65.

    Revenue

    n/a
    		 2.98M

    Gross Profit

    n/a
    		 -3.15M

    Operating Income

    n/a
    		 -202.47M

    Net Income

    n/a
    		 -195.88M

    EBITDA

    n/a
    		 -196.34M

    EBIT

    n/a
    		 -202.47M

    Earnings Per Share (EPS)

    n/a
    		 -1.65
    Full Income Statement

    Balance Sheet

    The company has 182.48M in cash and 40.79M in debt, giving a net cash position of 141.68M.

    Cash & Cash Equivalents

    n/a
    		 182.48M

    Total Debt

    n/a
    		 40.79M

    Net Cash

    n/a
    		 141.68M

    Retained Earnings

    n/a
    		 -687.21M

    Total Assets

    n/a
    		 328.16M

    Working Capital

    n/a
    		 129.48M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -122.86M and capital expenditures -7.29M, giving a free cash flow of -130.16M.

    Operating Cash Flow

    n/a
    		 -122.86M

    Capital Expenditures

    n/a
    		 -7.29M

    Free Cash Flow

    n/a
    		 -130.16M

    FCF Per Share

    n/a
    		 -1.1
    Full Cash Flow Statement

    Margins

    Gross margin is -105.43%, with operating and profit margins of -6787.36% and -6566.61%.

    Gross Margin

    n/a
    		 -105.43%

    Operating Margin

    n/a
    		 -6787.36%

    Pretax Margin

    n/a
    		 -6566.61%

    Profit Margin

    n/a
    		 -6566.61%

    EBITDA Margin

    n/a
    		 -6581.93%

    EBIT Margin

    n/a
    		 -6787.36%

    FCF Margin

    n/a
    		 -4363.36%

    Dividends & Yields

    PRME does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for PRME is $10, which is 300% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $10

    Price Target Difference

    n/a
    		 300%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 7
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -4.18

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist